Rehabilitation Following Critical Illness
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The principal research question to be answered by this study is whether an exercise based rehabilitative intervention following critical illness can generate improvements in exercise capacity and quality of life beyond current (usual) care. The investigators will also aim to demonstrate that such an intervention is both practical and cost-effective.
| Condition | Intervention |
|---|---|
|
Critical Illness Myopathy |
Other: Pulmonary Rehabilitation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Randomised Controlled Trial of Rehabilitation Following Critical Illness: A Short Term Feasibility and Follow-Up Pilot Study |
- Incremental Shuttle Walk Test [ Time Frame: Eight weeks ] [ Designated as safety issue: No ]
- Health Related Quality of Life [ Time Frame: Eight weeks ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 148 |
| Study Start Date: | November 2009 |
| Estimated Study Completion Date: | August 2012 |
| Estimated Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| No Intervention: Control | |
|
Experimental: Intervention
Pulmonary Rehabilitation
|
Other: Pulmonary Rehabilitation
Eight week programme of twice-weekly (sixteen sessions) supervised exercise and education sessions. Exercise will include aerobic cardiovascular and upper and lower limb strengthening exercises. Each session will comprise a warm-up period, followed by individualised exercises, and completed with a cool-down, and last approximately 40minutes. Aerobic exercise will be prescribed based on the results of walking tests and include walking, step-ups, cycling, and strength prescription according to the repetition maximum principle. Patients will complete three sets using this weight. Furthermore Borg scores will be used within each session to guide and direct exercise intensity. A home exercise programme will also be designed and accompanied by a manual detailing the individual warm-up, exercises and cool-down, and diary sections to record independent activity. Each session will also include an education session where relevant. |
Detailed Description:
Advances in medicine mean that an increasing number of critically ill people, including those with severe pneumonia (lung infection), chronic obstructive pulmonary disease (also known as emphysema or chronic bronchitis) or the "acute respiratory distress syndrome", survive admission to the hospital intensive care unit. Survivors report health problems such as breathlessness and weakness long after discharge. In a study monitoring over 800 patients discharged from an intensive care ward, over half required some form of caregiver assistance after 1-year.
Whilst on intensive care, patients usually require help to breathe from a ventilator machine and become immobilised. This leads to weak breathing muscles in three quarters of patients, as well as weak and wasted arm and leg muscles. Survivors struggle to regain their previous level of daily activity and function, limited by shortness of breath, muscle weakness and tiredness. It is recognised that people with chronic lung problems, such as chronic obstructive pulmonary disease, face similar problems. In this condition, exercise based therapy has been shown to improve muscle strength, walking ability, shortness of breath, and importantly quality of life.
Given these experiences, a new trial will evaluate a novel programme of exercise-based rehabilitation training in patients discharged from intensive care. The programme will last for 8-weeks and will use exercises designed to correct the breathing and limb muscle weakness, as well as education to help patients cope more effectively. The programme will begin as soon as possible following discharge from hospital and will be conducted on a mostly outpatient basis until the course is completed. By speeding the recovery of strength and activity, it is anticipated that quality of life will be improved, which this trial will attempt to measure.
The rehabilitation programme will include aerobic cardiovascular, and upper and lower limb strengthening exercises, in addition to relevant education sessions.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age >18 years AND admitted to critical care unit
- Ventilated >48-hours (via endotracheal tube) OR received continuous non- invasive ventilation (NIV)/non-invasive continuous positive airways pressure (CPAP)
- Admitted to ICU > 48-hours and evidence of SIRS
- Glasgow Coma Score (GCS) 15 (of 15) AND Abbreviated Mini-Mental Test Score (AMMTS) >/= 8 (of 10) on enrolment into rehabilitation programme
- Mobilising on ward to a degree sufficient as to begin a majority of proposed exercises. Clinical stability for observed exercise as judged by trial team is a prerequisite.
- Participant willingness to complete a programme of exercise based therapy aimed at reducing weakness and shortness of breath: subjective weakness or dyspnoea relative to their pre-admission state is implicit
Exclusion Criteria:
- Patients referred for terminal care or prognosis likely to be less than 12-months
- Unstable coronary artery syndrome
- Limb amputation (given special requirement for orthotics/rehabilitation)
- Critical peripheral vascular disease awaiting re-vascularisation procedure (or claudication distance <100 metres)
- Stroke with hemiparesis (likely need for specialised rehabilitation/stay on stroke unit)
- Severe, disabling locomotor problem or severe burns, which prevent effective participation in the exercises contained in the rehabilitation programme.
- Psychiatric disease necessitating anti-psychotic medication, deliberate drug overdose as the admitting ICU indication, ongoing treatment for drug or alcohol addiction, persons of no fixed abode post-discharge
- Patients undergoing renal haemodialysis (given the associated commitment to outpatient attendance)
- Extra contractual ICU referral (only if distance greater than suitable for twice weekly travel)
Additional exclusion criteria for muscle biopsy samples:
- Coagulopathy e.g. warfarin use
Contacts and Locations| Contact: Nicholas Hart, BSc (Hons), MBBS, MRCP, PhD | +44 207 188 7608 | nicholas.hart@gstt.nhs.uk |
| Contact: Bronwen Connolly, BSc (Hons), MSc | +44 203 299 9000 ext 2080 | bronwen.connolly@nhs.net |
| United Kingdom | |
| St.Thomas' Hospital | Recruiting |
| London, United Kingdom, SE1 7EH | |
| Contact: Nicholas Hart, BSc (Hons), MBBS, MRCP, PhD +44 207 188 7608 nicholas.hart@gstt.nhs.uk | |
| Contact: Bronwen Connolly, BSc (Hons), MSc +44 203 299 9000 ext 2080 bronwen.connolly@nhs.net | |
| Principal Investigator: Bronwen Connolly, BSc (Hons), MSc | |
| King's College Hospital | Recruiting |
| London, United Kingdom, SE5 9RS | |
| Contact: Bronwen Connolly, BSc (Hons), MSc +44 203 299 9000 ext 2080 bronwen.connolly@nhs.net | |
| Principal Investigator: Bronwen Connolly, BSc (Hons), MSc | |
| Study Director: | Nicholas Hart, BSc (Hons), MBBS, MRCP, PhD | St.Thomas' Hospital |
More Information
No publications provided
| Responsible Party: | Bronwen Connolly, Clinical Research Fellow, Guy's and St Thomas' NHS Foundation Trust |
| ClinicalTrials.gov Identifier: | NCT00976807 History of Changes |
| Other Study ID Numbers: | RJ1 09/N153 |
| Study First Received: | September 11, 2009 |
| Last Updated: | November 22, 2011 |
| Health Authority: | United Kingdom: National Health Service |
Keywords provided by Guy's and St Thomas' NHS Foundation Trust:
|
critical care intensive care weakness |
myopathy paresis rehabilitation |
Additional relevant MeSH terms:
|
Critical Illness Muscular Diseases Disease Attributes Pathologic Processes |
Musculoskeletal Diseases Neuromuscular Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on May 23, 2013